AADXOXX

ETF / Mutual Fund
NASDAQ
Citibank, N.A. Point to Point CD AADXOXX
Price Chart
Overview

About AADXOXX

Adynxx is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for pain and inflammatory diseases. They utilize transcription factor decoy technology to create first-in-class therapies with disease-modifying properties.

AUM
Volume
Avg. Volume
Expense Ratio

Top Holdings

Other
100.00%

Sector Allocation

Other100.00%

Country Allocation

Other100.00%

Fund Information

Exchange
NASDAQ
Sector
Latest News for AADXOXX
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AADXOXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AADXOXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM
Volume
Expense Ratio
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AADXOXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025